Interaction involving tadalafil and CYP3A4 inhibition by ritonavir

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 3, 2011, Pages 239-240

  Loulergue, Pierre ^a,b,c   Gaillard, Raphaël ^a,d   Mir, Olivier ^a,e  

^a LIPADE   (France)

^b INSERM   (France)

^c Teaching Hospital Cochin   (France)

^d Department of Psychiatry   (France)

^e Clinical Research Unit ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

FOSAMPRENAVIR; RITONAVIR; TADALAFIL; TENOFOVIR DISOPROXIL; ZIDOVUDINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG POTENTIATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; LIVER FUNCTION TEST; MALE; PRIAPISM; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CARBOLINES; CYTOCHROME P-450 CYP3A; DRUG INTERACTIONS; HIV INFECTIONS; HUMANS; MALE; PRIAPISM; RITONAVIR;

EID: 79951659621     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2010.526139     Document Type: Letter

References (8)

1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30: 239-45. (Pubitemid 12149145)
2. Back DJ. Re: ' P harmacokinetic interactions between sildenafi l and saquinavir/ritonavir ' . Br J Clin Pharmacol 2000; 50:85.
3. Shabsigh R, Seftel AD, Rosen RC, Porst H, Ahuja S, Deeley MC, et al. Review of time of onset and duration of clinical effi cacy of phosphodiesterase type 5 inhibitors in treatment of erectile dysfunction. Urology 2006;68:689-96. (Pubitemid 44633385)
4. Cialis (tadalafi l) full prescribing information. Indianapolis, IN: Eli-Lilly; 2007. Available at: http://pi.lilly.com/us/ cialis-pi.pdf (accessed date is 2007).
5. Zeldin RK, Petruschke RA. Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients. J Antimicrob Chemother 2004;53:4-9. (Pubitemid 38072176)
6. Galatti L, Fioravanti A, Salvo F, Polimeni G, Giustini SE. Interaction between tadalafi l and itraconazole. Ann Pharmacother 2005;39:200.
7. Muirhead GJ, Wulff MB, Fielding A, Kleinermans D, Buss N. Pharmacokinetic interactions between sildenafi l and saquinavir/ritonavir. Br J Clin Pharmacol 2000;50: 99-107.
8. National Library of Medicine. DailyMed. Current medication information. Bethesda, MD: US NLM; 2010. Available at: http://dailymed.nlm.nih.gov/dailymed/ drugInfo (access date is 2007). page has moved to http://0-dailymed. nlm.nih.gov.www.elgar.govt.nz/dailymed/drugInfo. cfm?id=21906. date of publication is 2010.